Differential biotransformation of dynorphin A(1-17) and dynorphin A(1-13) peptides in human blood, ex vivo

被引:0
|
作者
Chou, JZ [1 ]
Chait, BT [1 ]
Wang, R [1 ]
Kreek, MJ [1 ]
机构
[1] ROCKEFELLER UNIV,LAB BIOL ADDICT DIS,NEW YORK,NY 10021
关键词
dynorphin A; biotransformation; human blood; ex vivo studies;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The biotransformation in human blood in vitro of three dynorphin A (Dyn A) peptides was studied by matrix-assisted laser desorption mass spectrometry to determine whether the natural peptide, Dyn A(1-17), is biotransformed differently from Dyn A(1-13), the natural sequence shortened form used in numerous neurobiological and pharmacological studies. In addition to studies of Dyn A(1-17), a natural product from prodynorphin and Dyn At 1-13), a natural sequence truncation of Dyn At 1-17), Dyn (1-10)amide, a synthetic analogue of Dyn A(1-17)presumed to be protected from rapid biotransformation was also studied. Synthetic Dyn A peptides were incubated in freshly drawn blood for various periods of time prior to mass spectrometric analysis. Several peptide products were identified from each precursor; the time profiles of appearance and disappearance of the major products were followed. Substantial differences in products and especially in the rate of biotransformation were observed between the processing of Dyn A(1-17) and the two shorter Dyn A peptides, Dyn A(1-13) and Dyn A(1-10)amide. Significant amounts of the natural Dyn A(1-17) survived 4 h of incubation (half-life 3 h). Dyn A (2-17), a major processed product of Dyn A(1-17) in blood, continued to accumulate during the 4-h incubation period. By contrast, both Dyn A(1-13) and Dyn A(1-10)amide were biotransformed very rapidly with half-lives of < 1 min and 10 min, respectively. Most of the products from these two peptide precursors were also further processed rapidly, with the exception of Dyn A(4-12) and Dyn A(4-10)amide, which were detected for over 2 h. Dyn A(1-6) was found as a minor biotransformation product from all three precursor peptides. These findings suggest that an important function of the four C-terminal amino acid residues of the natural form, Dyn A(1-17) [compared to Dyn At 1-13)], is to stabilize or protect the peptide from biotransformation by enzymes, by preserving a natural hairpin structure possibly near the carboxyl-terminus.
引用
收藏
页码:983 / 990
页数:8
相关论文
共 50 条
  • [1] CARDIOVASCULAR EFFECTS OF DYNORPHIN A-(1-8), DYNORPHIN A-(1-13) AND DYNORPHIN A-(1-17) MICROINJECTED INTO THE PREOPTIC MEDIALIS NUCLEUS OF THE RAT
    FEUERSTEIN, G
    FADEN, AI
    [J]. NEUROPEPTIDES, 1984, 5 (1-3) : 295 - 298
  • [2] BIOTRANSFORMATION OF DYNORPHIN (1-17) BY RAT-BRAIN PEPTIDASES
    GRIFFITHS, EC
    LONGSON, D
    WHITTAM, A
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 1983, 342 (SEP): : P39 - P40
  • [3] Dynorphin 1-17 biotransformation peptides: properties, challenges and solutions for future therapeutics development
    Ballouze, Rama
    Salhimi, Salizawati Muhamad
    Mohtar, Noratiqah
    Fazalul Rahiman, Siti Sarah
    [J]. FUTURE MEDICINAL CHEMISTRY, 2023, 15 (09) : 791 - 808
  • [4] DEGRADATION OF DYNORPHIN-(1-13) AND DYNORPHIN-(1-17) BY THE NEUROBLASTOMA CELL-MEMBRANE - EVIDENCE FOR THE INVOLVEMENT OF A CYSTEINE PROTEASE
    SATOH, M
    YOKOSAWA, H
    ISHII, S
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1986, 140 (01) : 335 - 341
  • [5] Metabolism of dynorphin A(1-13)
    Brugos, B
    Hochhaus, G
    [J]. PHARMAZIE, 2004, 59 (05): : 339 - 343
  • [6] DYNORPHIN-A (1-13) POTENTIATES DYNORPHIN-A (1-17) ON LOSS OF THE TAIL-FLICK REFLEX AFTER INTRATHECAL INJECTION IN THE RAT
    QU, ZX
    ISAAC, L
    [J]. BRAIN RESEARCH, 1993, 610 (02) : 340 - 343
  • [7] INFLUENCE OF DYNORPHIN A/1-10/AMIDE, DYNORPHIN A/1-13
    STAREC, M
    WAITZOVA, D
    ELIS, J
    [J]. ACTIVITAS NERVOSA SUPERIOR, 1986, 28 (04): : 324 - 326
  • [8] Human pharmacology of the opioid neuropeptide dynorphin A(1-13)
    Greenwald, MK
    Stitzer, ML
    Haberny, KA
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1997, 281 (03): : 1154 - 1163
  • [9] A mixture of three peptidase inhibitors increases antinociceptive effects of dynorphin A (1-17) or dynorphin A (1-13) by intracerebroventricularl administration in rats via mainly μ- and κ-opioid receptors
    Ajimi, J.
    Yoshikawa, M.
    Miura, M.
    Takahashi, S.
    Suzuki, T.
    [J]. EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2014, 31 : 142 - 142
  • [10] Effect of three peptidase inhibitors on antinociceptive potential and toxicity with intracerebroventricular administration of dynorphin A (1-17) or (1-13) in the rat
    Ajimi, Junko
    Yoshikawa, Masanobu
    Takahashi, Shigeru
    Miura, Masaaki
    Tsukamoto, Hideo
    Kawaguchi, Mitsuru
    Kobayashi, Hiroyuki
    Suzuki, Toshiyasu
    [J]. JOURNAL OF ANESTHESIA, 2015, 29 (01) : 65 - 77